Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury
- 28 July 2016
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 36 (4) , 576-583
Abstract
Summary The aim of this study was to investigate the possible beneficial role of telmisartan in cerebral edema after traumatic brain injury (TBI) and the potential mechanisms related to the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) pyrin domain-containing 3 (NLRP3) inflammasome activation. TBI model was established by cold-induced brain injury. Male C57BL/6 mice were randomly assigned into 3, 6, 12, 24, 48 and 72 h survival groups to investigate cerebral edema development with time and received 0, 5, 10, 20 and 40 mg/kg telmisartan by oral gavage, 1 h prior to TBI to determine the efficient anti-edemic dose. The therapeutic window was identified by post-treating 30 min, 1 h, 2 h and 4 h after TBI. Blood-brain barrier (BBB) integrity, the neurological function and histological injury were assessed, at the same time, the mRNA and protein expression levels of NLRP3 inflammasome, IL-1β and IL-18 concentrations in peri-contused brain tissue were measured 24 h post TBI. The results showed that the traumatic cerebral edema occurred from 6 h, reached the peak at 24 h and recovered to the baseline 72 h after TBI. A single oral dose of 5, 10 and 20 mg/kg telmisartan could reduce cerebral edema. Post-treatment up to 2 h effectively limited the edema development. Furthermore, prophylactic administration of telmisartan markedly inhibited BBB impairment, NLRP3, apoptotic speck-containing protein (ASC) and Caspase-1 activation, as well as IL-1β and IL-18 maturation, subsequently improved the neurological outcomes. In conclusion, telmisartan can reduce traumatic cerebral edema by inhibiting the NLRP3 inflammasome-regulated IL-1β and IL-18 accumulation.Keywords
This publication has 35 references indexed in Scilit:
- Pathogenesis of Brain Edema and Investigation into Anti-Edema DrugsInternational Journal of Molecular Sciences, 2015
- Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activationCell Death & Differentiation, 2015
- Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activationNeuropharmacology, 2014
- NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhageAnnals of Neurology, 2013
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeCell Death & Disease, 2013
- Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionVascular Health and Risk Management, 2013
- Continuous hyperosmolar therapy for traumatic brain injury-associated cerebral edema: As good as it gets, or an iatrogenic secondary insult?Journal of Clinical Neuroscience, 2013
- Influence of Age on Brain Edema Formation, Secondary Brain Damage and Inflammatory Response after Brain Trauma in MicePLOS ONE, 2012
- Activation of P2X7 Promotes Cerebral Edema and Neurological Injury after Traumatic Brain Injury in MicePLOS ONE, 2012
- CHANGES IN CSF S100B AND CYTOKINE CONCENTRATIONS IN EARLY-PHASE SEVERE TRAUMATIC BRAIN INJURYShock, 2004